Skip to content
INCOVACC Gets Approved by DCGI
- Drugs Controller General of India (DCGI) has approved the World’s first Intranasal vaccine INCOVACC for SARS-CoV-2. It was developed by Hyderabad-based Bharat Biotech.
- Funded by: Partially by Department of Biotechnology (DBT), Government of India
- It is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.